Babich John W 4

4 · Molecular Insight Pharmaceuticals, Inc. · Filed Aug 12, 2009

Insider Transaction Report

Form 4
Period: 2009-08-11
Babich John W
DirectorPresident, CEO and CSO
Transactions
  • Award

    Employee Stock Option (right to buy)

    2009-08-11+50,00050,000 total
    Exercise: $5.70Exp: 2019-08-11Common stock (50,000 underlying)
Footnotes (1)
  • [F1]The options will vest and become exercisable upon achievement by the reporting person of certain performance based milestones.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24.4_297023

    POA DOCUMENT